HUPO 2022 World Congress

#HUPO 2022 Starts December 4, 2022

Call for Abstracts

Abstract Submission is Now Open!

The HUPO 2022 Congress Core Committee invites submission of abstracts for oral and poster presentations, as well as for the HUPO Poster Competition.

Important Dates

Abstract Submission Opens May 5, 2022
Abstract Submission Deadline July 8, 2022 (23:59 PDT)
Abstract Notifications August 12, 2022
Early Registration Deadline August 31, 2022 (23:59 PDT)
Presenting Author Registration Deadline October 14, 2022 (23:59 PDT)

Abstract Submission Guidelines

  • An abstract may have only one presenting author. There is no limit to the number of co-authors per abstract.
  • A presenter may only present one poster.
    • Prepare the following sections in plain English text for pasting into the appropriate text boxes during submission. Abstracts cannot be edited after submission. See an example abstract here.
    • Title (maximum 20 words)
    • Authors and affiliations
    • Structure the abstract body (maximum 300 words) with the following headings:
      • Introduction
      • Methods
      • Results
      • Conclusions
      • (References optional)

Scientific posters may be submitted by a company through the regular on-line mechanism. However, if the poster is only reporting about the capabilities of a product (e.g., instrument, ancillary device, kit, reagent, software) and does not have a main scientific focus, it can only be considered in the Corporate Poster category, for which there is a fee and a designated presentation location in the poster hall.

  • All authors of the abstract have reviewed the abstract and confirm that all information is correct. The authors accept that the content of this abstract cannot be modified or corrected after final submission, and they are aware that it will be published exactly as submitted.
  • Submission of the abstract constitutes consent of all authors of the abstract to publication in relation to the meeting (e.g. conference website, programs, other promotions, etc.). All authors of the abstract warrant and represent that they either are the sole owners of, or have all necessary rights to sublicense, all the information and content in the abstract provided to HUPO and its conference organizers and that publication of the abstract does not infringe any rights, including, but not limited to, intellectual property rights, of any third parties.
  • Contact author and is the person who will be notified about the status of the abstract by the meeting organizers. The presenter of the abstract is responsible for informing the other authors about the status of the abstract. If the abstract is accepted for publication at the Conference, the presenter, on behalf of all authors, agrees that it may be published on the Conference website or elsewhere, either prior to or contemporaneously with the Conference, as well as in an Abstract Book that may be distributed in print and or electronically.
  • All authors of the abstract grant HUPO a royalty-free, perpetual, irrevocable, and nonexclusive license to use, reproduce, publish, translate, distribute, and display the abstract. All authors of the abstract grant permission to HUPO to record the audio and video portion, if any, of the abstract presentation at the conference and to collect and retain all revenues from all rebroadcasts (including web broadcasts), sales, and publications of such recordings.
  • HUPO reserves the right to remove from any publication any abstract that does not comply with the above.
  • The copyright of the abstract outside of HUPO’s usage remains with the authors of the abstract.

  • Chemical Proteomics/Drug
  • Development
    Clinical Proteomics/Precision Medicine
  • Computational Proteomics
  • COVID-19 Proteomics
  • Data translation into biological insights
  • Disease Proteomics/Cancer Proteomics
  • Glycoproteomics
  • HPP
  • Immunopeptidomics
  • Microbiome/Metaproteomics
  • MS-free Proteomics
  • Plant Proteomics
  • Plasma Proteomics
    Posttranslational Modifications
  • Protein Protein Interaction and Spatial Proteomics
  • Proteogenomics
  • Proteomics and Infectious Diseases
  • Single Cell Proteomics
  • Structural Proteomics
  • Technological Advancements in Proteomics
  • Top Down Proteomics

For any inquiries, please contact hupo2022-program@icsevents.com. Please include your abstract number in your email.

Step-by-Step Submission Guidelines

Step 1. Abstract Title

  • Maximum 20 words.
  • Abstracts can be submitted for either oral or poster presentation. Please indicate your preferred presentation format. If you would not be comfortable giving an oral presentation, please select “Poster Presentation”.

NOTE: Selecting oral format does not guarantee you will be assigned an oral abstract presentation upon acceptance; the final presentation type is determined by the Core Committee.

Step 2. Topic

  • Please select one topic that best suits your abstract.

Step 3. Authors and Affiliations

  • Designate the presenting author.
  • There is no limit to the number of co-authors per abstract

Step 4. Abstract Text

  • Abstract text cannot exceed 300 words and must be input with the following headings:
    • Introduction
    • Methods
    • Results
    • Conclusions
    • (References optional)

Poster Competition

  • Please tick if you wish to compete in the Poster Competition.

RULES: Entrant must be a current Graduate Student (PhD or Masters) and present a poster during HUPO 2022. 15 posters in each trainee category (graduate students and postdocs) will be pre-selected based on the quality, novelty and potential impact of submitted abstracts. Posters will be visited by evaluators during the poster sessions at HUPO 2022 to select a winner and runner up for each level (graduate student and postdocs). Award winners will be highlighted during the HUPO 2022 Closing Ceremony & Awards Session.

Corporate Poster

  • Please tick if this is a Corporate Poster (fees apply)

Scientific posters may be submitted by a company through the regular on-line mechanism. However, if the poster is only reporting about the capabilities of a product (e.g., instrument, ancillary device, kit, reagent, software) and does not have a main scientific focus, it can only be considered in the Corporate Poster category, for which there is a fee and a designated presentation location in the poster hall.

Step 5. Preview & Submit

  • Please proofread your abstract. Once submitted, you will not be able to make any changes.
  • A system-generated acknowledgement email with your abstract number will be sent to your registered email address. If you do not receive this email, please check junk mail box before contacting us.

Contact Us